Zypitamag (pitavastatin) tablets: a pharmaceutical alternative to Livalo. Zypitamag was introduced to the U.S. market in 2017 to improve patient access to pitavastatin.
Zypitamag is covered for over 150 million Americans and is available to most patients at near generic pricing. Through our savings program, eligible patients receive 30-days of Zypitamag FREE followed by a $10/month co-pay. For uninsured patients, Zypitamag is available at a price of $29/month for a 90-day prescription.
Eligibility criteria apply.
A division of Tarsus Medical owned by Tarsus Group
